Table 1.
Main demographic clinical and diagnostic characteristics and CD200 levels in the study population.
| Psoriasis vulgaris (n=30) | Pemphigus vulgaris (n=15) | Healthy controls (n=25) | p-value | |
|---|---|---|---|---|
| Age (year) | 41.6±14.3 | 51.2±13.7 | 45.7±15.4 | 0.143** |
| Gender | ||||
| Women, n (%) | 15 (50) | 6 (40) | 11 (44) | 0.799* |
| Men, n (%) | 15 (50) | 9 (60) | 14 (56) | |
| PASI | 4.1±3.0 | – | – | – |
| PDAI | – | 20.8±22.2 | – | – |
| Anti-desmoglein 3 (RU/mL) Anti-desmoglein 1 (RU/mL) |
– | 163.1±43.1 40.4±53.4 |
– | – |
| Serum soluble CD200 (pg/mL) | 96.7±15.8 | 76.2±14.6 | 26.8±7.0 | <0.001** |
*
chi-square test;
**
ANOVA;
PASI – Psoriasis Area and Severity Index; PDAI – Pemphigus patients for pemphigus Disease Area Index.